SCHEMBL18636334

SCHEMBL18636334

C=C[C@]1(C)[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(OCC)nc(N)nc21

nearest known ligand 0.48

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 6/20 0.48
▸ ADORA3 P0DMS8 3/20 0.44
▸ ADORA1 P30542 3/20 0.44
▸ ADORA2B P29275 3/20 0.44
▸ CYP2C19 P33261 1/20 0.43
▸ ADA P00813 1/20 0.43
▸ SLC29A1 Q99808 5/20 0.42
▸ ALOX15 P16050 1/20 0.40
▸ PGK1 P00558 1/20 0.39
▸ PGK2 P07205 1/20 0.39
▸ MGMT P16455 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18656236 0.88 ADORA2A (0.46) ADORA2AADORA3ADORA1ADORA2BCYP2C19
SCHEMBL9569382 0.86 ADORA2A (0.49) ADORA2AADORA3ADORA1ADORA2BCYP2C19
SCHEMBL15763449 0.86 ADORA2A (0.54) ADORA2AADORA3ADORA1ADORA2BCYP2C19
SCHEMBL14770011 0.86 ADORA2A (0.65) ADORA2AADORA3ADORA1ADORA2BCYP2C19
SCHEMBL721112 0.86 ADORA2A (0.65) ADORA2AADORA3ADORA1ADORA2BCYP2C19
SCHEMBL13468485 0.86 ADORA2A (0.54) ADORA2AADORA3ADORA1ADORA2BCYP2C19
SCHEMBL2499694 0.86 ADORA2A (0.65) ADORA2AADORA3ADORA1ADORA2BCYP2C19
SCHEMBL29722454 0.86 ADORA2A (0.65) ADORA2AADORA3ADORA1ADORA2BCYP2C19
SCHEMBL18656252 0.85 ADORA2A (0.51) ADORA2AADORA3ADORA1ADORA2BCYP2C19
SCHEMBL13030120 0.85 ADORA2A (0.51) ADORA2AADORA3ADORA1ADORA2BCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2755983-B1 SUBSTITUTED CARBONYLOXYMETHYLPHOSPHORAMIDATE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS IDENIX PHARMACEUTICALS LLC (US) 2017-03-15 — — EP disclosed
Send feedback